Sort
85,873 grants matching “alzheimers”
Dementia with Lewy Bodies Consortium
$2,127,650James Bruce Leverenz · Cleveland Clinic Lerner Com-Cwru · U01 · FY2023 · NS
The regulation of synaptic transmission and neural circuit function
$2,127,216Wei Lu · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Alzheimer Disease Research Center
$2,126,939Helena Chang Chui · University Of Southern California · P50 · FY2019 · AG
Are mechanisms leading to FAD, SAD and age-associated cognitive decline similar?
$2,126,894Luciano D'adamio · Rbhs-New Jersey Medical School · RF1 · FY2019 · AG
Alzheimer's Disease Risk Genes in Human Microglia and Neurons Derived from iPSCs
$2,126,485Li-Huei Tsai · Massachusetts Institute Of Technology · RF1 · FY2014 · AG
Human Retinal Imaging Biomarkers for FTLD-Tau in Relation to FTLD-TDP and Nonamnestic AD
$2,126,420Benjamin J. Kim · University Of Pennsylvania · RF1 · FY2023 · AG
C9orf72 frontotemporal dementia (FTD) and amyotrophic lateral sclerosis(ALS): using patient cells and CRISPR to reveal therapeutic approaches
$2,126,250Bruce R Conklin · J. David Gladstone Institutes · RF1 · FY2021 · AG
Neuronal Protective Apolipoprotein E2-mediated endocytic and exocytic pathways
$2,124,773Efrat Levy · New York University School Of Medicine · RF1 · FY2017 · AG
The Role of Inflammation and NGF Dysfunction in the Evolution of Alzheimer Disease Pathology in Down Syndrome-Revision
$2,124,233Jorge A Busciglio · University Of California-Irvine · RF1 · FY2019 · AG
Wyoming Sensory Biology COBRE
$2,124,041Qianquan Sun · University Of Wyoming · P20 · FY2025 · GM
Wyoming Sensory Biology COBRE
$2,124,041Qianquan Sun · University Of Wyoming · P20 · FY2023 · GM
The Frontotemporal Lobar Degeneration Neuroimaging Initiative
$2,123,727Howard J Rosen · University Of California, San Francisco · R01 · FY2009 · AG
COBRE Center for Central Nervous System Function
$2,123,322Jerome N Sanes · Brown University · P20 · FY2015 · GM
Leveraging novel mouse models to investigate toxic metal exposures on brain aging and Alzheimer's disease
$2,122,961Lee E Goldstein · Boston University Medical Campus · U01 · FY2024 · AG
Indiana Alzheimer Disease Center
$2,122,835Andrew J Saykin · Indiana University Indianapolis · P30 · FY2018 · AG
Indiana Alzheimer Disease Center
$2,122,835Andrew J Saykin · Indiana University Indianapolis · P30 · FY2017 · AG
PREVENTABLE Data Coordinating Center
$2,122,717Bradley G Hammill · Duke University · U19 · FY2022 · AG
Center of Biomedical Research Excellence in CNS Metabolism
$2,122,307Patrick G Sullivan · University Of Kentucky · P20 · FY2025 · GM
Polo-like-kinase-2-dependent α-Synuclein Serine-129 Phosphorylation: a Physiological RoleDuring Synaptic Activity
$2,121,853Ulf Dettmer · Brigham And Women'S Hospital · RF1 · FY2022 · NS
Identifying microscopic vasculature within entorhinal cortex in healthy aging and its proximity to pathology profiles in Alzheimer's disease
$2,121,694Jean Augustinack · Massachusetts General Hospital · RF1 · FY2023 · AG
MASSACHUSETTS ALZHEIMERS DISEASE RESEARCH CENTER
$2,121,363Massachusetts General Hospital · P50 · FY2003 · AG
PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
$2,121,223Roberta Diaz Brinton · University Of Arizona · R01 · FY2022 · AG
Mechanisms by which ABCA7 activity influences Alzheimer's Disease
$2,121,130Daniel James Rader · University Of Pennsylvania · RF1 · FY2022 · AG
Pre-Clinical Testing Core
$2,120,993Paul Richard Territo · Indiana University Indianapolis · U54 · FY2024 · AG
Pre-Clinical Testing Core
$2,120,992Paul Richard Territo · Indiana University Indianapolis · U54 · FY2025 · AG